instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis'. | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | ALDESLEUKIN, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, IPILIMUMAB, NIVOLUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis'. | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | ALDESLEUKIN, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, IPILIMUMAB, NIVOLUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant melanoma'. | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | ALDESLEUKIN, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, IPILIMUMAB, NIVOLUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myalgia'. | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | ALDESLEUKIN, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, IPILIMUMAB, NIVOLUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Parotitis'. | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | ALDESLEUKIN, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, IPILIMUMAB, NIVOLUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Performance status decreased'. | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | ALDESLEUKIN, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, IPILIMUMAB, NIVOLUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | ALDESLEUKIN, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, IPILIMUMAB, NIVOLUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Squamous cell carcinoma of head and neck'. | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | ALDESLEUKIN, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, IPILIMUMAB, NIVOLUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thyroid cancer'. | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | ALDESLEUKIN, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, IPILIMUMAB, NIVOLUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thyroiditis'. | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | ALDESLEUKIN, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, IPILIMUMAB, NIVOLUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
What was the administration route of drug 'ALDESLEUKIN'? | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
What was the dosage of drug 'ALDESLEUKIN'? | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | UNK, 2 MIE PER DAY FOR 14 DAYS | DrugDosageText | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | 60 MILLIGRAM/KILOGRAM X2 | DrugDosageText | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
What was the dosage of drug 'FLUDARABINE PHOSPHATE'? | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | 25 MILLIGRAM PER MILLILITRE SQUARE X 5 | DrugDosageText | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
What was the dosage of drug 'IPILIMUMAB'? | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | 3 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
What was the dosage of drug 'NIVOLUMAB'? | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | 3 MILLIGRAM/KILOGRAM, Q2WK X 4 | DrugDosageText | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
What was the dosage of drug 'PEGFILGRASTIM'? | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | 6 MILLIGRAM | DrugDosageText | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
What was the outcome of reaction 'Cholangiocarcinoma'? | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | Not recovered | ReactionOutcome | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
What was the outcome of reaction 'Death'? | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | Fatal | ReactionOutcome | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
What was the outcome of reaction 'Squamous cell carcinoma of head and neck'? | Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has shown remarkable results in malignant melanoma (MM), while studies on the potential in other cancer diagnoses are sp... | Not recovered | ReactionOutcome | CC BY-NC | 34607899 | 20,020,114 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Virologic failure'. | Hepatitis B screening practices and viral control among persons living with HIV in urban Senegal.
Chronic hepatitis B virus (HBV) infection affects >10% of the general population and is the leading cause of liver cirrhosis and cancer in West Africa. Despite current recommendations, HBV is often not tested for in clinic... | LAMIVUDINE, LOPINAVIR\RITONAVIR, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC-ND | 34610183 | 19,984,012 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | AMLODIPINE BESYLATE, CHOLECALCIFEROL, ESCITALOPRAM OXALATE, HYDROXYZINE HYDROCHLORIDE, INDAPAMIDE, MEMANTINE HYDROCHLORIDE, OMEPRAZOLE, PIRACETAM, RAMIPRIL | DrugsGivenReaction | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anxiety'. | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | AMLODIPINE BESYLATE, CHOLECALCIFEROL, ESCITALOPRAM OXALATE, HYDROXYZINE HYDROCHLORIDE, INDAPAMIDE, MEMANTINE HYDROCHLORIDE, OMEPRAZOLE, PIRACETAM, RAMIPRIL | DrugsGivenReaction | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Balance disorder'. | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | AMLODIPINE BESYLATE, CHOLECALCIFEROL, ESCITALOPRAM OXALATE, HYDROXYZINE HYDROCHLORIDE, INDAPAMIDE, MEMANTINE HYDROCHLORIDE, OMEPRAZOLE, PIRACETAM, RAMIPRIL | DrugsGivenReaction | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gait disturbance'. | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | AMLODIPINE BESYLATE, ESCITALOPRAM OXALATE, INDAPAMIDE, MEMANTINE, RAMIPRIL, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC | 34610667 | 20,264,715 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | AMLODIPINE BESYLATE, CHOLECALCIFEROL, ESCITALOPRAM OXALATE, HYDROXYZINE HYDROCHLORIDE, INDAPAMIDE, MEMANTINE HYDROCHLORIDE, OMEPRAZOLE, PIRACETAM, RAMIPRIL | DrugsGivenReaction | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somatic symptom disorder'. | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | AMLODIPINE BESYLATE, CHOLECALCIFEROL, ESCITALOPRAM OXALATE, HYDROXYZINE HYDROCHLORIDE, INDAPAMIDE, MEMANTINE HYDROCHLORIDE, OMEPRAZOLE, PIRACETAM, RAMIPRIL | DrugsGivenReaction | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Speech disorder'. | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | ALPRAZOLAM, ASPIRIN, ATORVASTATIN, ESCITALOPRAM OXALATE, GINKGO, LUTEIN, PANTOPRAZOLE | DrugsGivenReaction | CC BY-NC | 34610667 | 20,042,358 | 2021-09 |
What was the administration route of drug 'INDAPAMIDE'? | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | Oral | DrugAdministrationRoute | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
What was the administration route of drug 'RAMIPRIL'? | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | Oral | DrugAdministrationRoute | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | Oral | DrugAdministrationRoute | CC BY-NC | 34610667 | 20,264,715 | 2021-09 |
What was the dosage of drug 'CHOLECALCIFEROL'? | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | 2000 INTERNATIONAL UNIT, QD (2000 IU, QD) | DrugDosageText | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
What was the dosage of drug 'HYDROXYZINE HYDROCHLORIDE'? | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | 10 MILLIGRAM, QD (10 MG, QD) | DrugDosageText | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
What was the dosage of drug 'OMEPRAZOLE'? | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | 20 MILLIGRAM, QD (20 MG, QD) | DrugDosageText | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
What was the outcome of reaction 'Balance disorder'? | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | Recovered | ReactionOutcome | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
What was the outcome of reaction 'Fall'? | Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports.
The consumption of new selective serotonin reuptake inhibitors (SSRIs) is raising dramatically especially in European countries. It contributes to occurrence of clinically important drug side effects. One of which can be hyponatremia. ... | Recovered | ReactionOutcome | CC BY-NC | 34610667 | 20,183,764 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alanine aminotransferase increased'. | Rickettsia burneti and Brucella melitensis co-infection: a case report and literature review.
Rickettsia is the pathogen of Q fever, Brucella ovis is the pathogen of brucellosis, and both of them are Gram-negative bacteria which are parasitic in cells. The mixed infection of rickettsia and Brucella ovis is rarely repor... | DOXYCYCLINE, RIFAMPIN | DrugsGivenReaction | CC BY | 34610810 | 20,102,034 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspartate aminotransferase increased'. | Rickettsia burneti and Brucella melitensis co-infection: a case report and literature review.
Rickettsia is the pathogen of Q fever, Brucella ovis is the pathogen of brucellosis, and both of them are Gram-negative bacteria which are parasitic in cells. The mixed infection of rickettsia and Brucella ovis is rarely repor... | DOXYCYCLINE, RIFAMPIN | DrugsGivenReaction | CC BY | 34610810 | 20,102,034 | 2021-10-05 |
What was the administration route of drug 'DOXYCYCLINE'? | Rickettsia burneti and Brucella melitensis co-infection: a case report and literature review.
Rickettsia is the pathogen of Q fever, Brucella ovis is the pathogen of brucellosis, and both of them are Gram-negative bacteria which are parasitic in cells. The mixed infection of rickettsia and Brucella ovis is rarely repor... | Oral | DrugAdministrationRoute | CC BY | 34610810 | 20,102,034 | 2021-10-05 |
What was the administration route of drug 'RIFAMPIN'? | Rickettsia burneti and Brucella melitensis co-infection: a case report and literature review.
Rickettsia is the pathogen of Q fever, Brucella ovis is the pathogen of brucellosis, and both of them are Gram-negative bacteria which are parasitic in cells. The mixed infection of rickettsia and Brucella ovis is rarely repor... | Oral | DrugAdministrationRoute | CC BY | 34610810 | 20,102,034 | 2021-10-05 |
What was the outcome of reaction 'Alanine aminotransferase increased'? | Rickettsia burneti and Brucella melitensis co-infection: a case report and literature review.
Rickettsia is the pathogen of Q fever, Brucella ovis is the pathogen of brucellosis, and both of them are Gram-negative bacteria which are parasitic in cells. The mixed infection of rickettsia and Brucella ovis is rarely repor... | Recovered | ReactionOutcome | CC BY | 34610810 | 20,102,034 | 2021-10-05 |
What was the outcome of reaction 'Aspartate aminotransferase increased'? | Rickettsia burneti and Brucella melitensis co-infection: a case report and literature review.
Rickettsia is the pathogen of Q fever, Brucella ovis is the pathogen of brucellosis, and both of them are Gram-negative bacteria which are parasitic in cells. The mixed infection of rickettsia and Brucella ovis is rarely repor... | Recovered | ReactionOutcome | CC BY | 34610810 | 20,102,034 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute monocytic leukaemia'. | Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.
Second-line treatment of endometrial cancer is an unmet medical need. We conducted a phase I study evaluating lurbinectedin and doxorubicin intravenously every 3 weeks in patients with solid tumors. The ... | DOXORUBICIN HYDROCHLORIDE, LURBINECTEDIN | DrugsGivenReaction | CC BY-NC | 34610971 | 20,048,905 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Second primary malignancy'. | Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.
Second-line treatment of endometrial cancer is an unmet medical need. We conducted a phase I study evaluating lurbinectedin and doxorubicin intravenously every 3 weeks in patients with solid tumors. The ... | DOXORUBICIN HYDROCHLORIDE, LURBINECTEDIN | DrugsGivenReaction | CC BY-NC | 34610971 | 20,048,905 | 2021-11 |
What was the administration route of drug 'DOXORUBICIN HYDROCHLORIDE'? | Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.
Second-line treatment of endometrial cancer is an unmet medical need. We conducted a phase I study evaluating lurbinectedin and doxorubicin intravenously every 3 weeks in patients with solid tumors. The ... | Intravenous bolus | DrugAdministrationRoute | CC BY-NC | 34610971 | 20,048,905 | 2021-11 |
What was the administration route of drug 'LURBINECTEDIN'? | Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.
Second-line treatment of endometrial cancer is an unmet medical need. We conducted a phase I study evaluating lurbinectedin and doxorubicin intravenously every 3 weeks in patients with solid tumors. The ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34610971 | 20,048,905 | 2021-11 |
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.
Second-line treatment of endometrial cancer is an unmet medical need. We conducted a phase I study evaluating lurbinectedin and doxorubicin intravenously every 3 weeks in patients with solid tumors. The ... | 50 MG/M2 OR 40 MG/M2, EVERY 3 WEEKS | DrugDosageText | CC BY-NC | 34610971 | 20,048,905 | 2021-11 |
What was the dosage of drug 'LURBINECTEDIN'? | Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.
Second-line treatment of endometrial cancer is an unmet medical need. We conducted a phase I study evaluating lurbinectedin and doxorubicin intravenously every 3 weeks in patients with solid tumors. The ... | 3.0/ 3.5/ 4.0/ 5.0 MG OR 2.0 MG/M2, INTRAVENOUSLY OVER 1 HOUR ON DAY 1 EVERY 3 WEEKS | DrugDosageText | CC BY-NC | 34610971 | 20,048,905 | 2021-11 |
What was the outcome of reaction 'Acute monocytic leukaemia'? | Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.
Second-line treatment of endometrial cancer is an unmet medical need. We conducted a phase I study evaluating lurbinectedin and doxorubicin intravenously every 3 weeks in patients with solid tumors. The ... | Fatal | ReactionOutcome | CC BY-NC | 34610971 | 20,048,905 | 2021-11 |
What was the outcome of reaction 'Second primary malignancy'? | Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.
Second-line treatment of endometrial cancer is an unmet medical need. We conducted a phase I study evaluating lurbinectedin and doxorubicin intravenously every 3 weeks in patients with solid tumors. The ... | Fatal | ReactionOutcome | CC BY-NC | 34610971 | 20,048,905 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Large mediastinal germ cell tumor with disease progression during systemic therapy.
A 29-year-old male developed acute onset severe shortness of breath and fevers and was found to have a 17 cm anterior mediastinal mass with immature teratoma and possible mixed germ cell tumor on biopsy. He remained hospitalized during ... | CISPLATIN, ETOPOSIDE, IFOSFAMIDE | DrugsGivenReaction | CC BY | 34611488 | 19,980,071 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Large mediastinal germ cell tumor with disease progression during systemic therapy.
A 29-year-old male developed acute onset severe shortness of breath and fevers and was found to have a 17 cm anterior mediastinal mass with immature teratoma and possible mixed germ cell tumor on biopsy. He remained hospitalized during ... | CISPLATIN, ETOPOSIDE, IFOSFAMIDE | DrugsGivenReaction | CC BY | 34611488 | 19,980,071 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Large mediastinal germ cell tumor with disease progression during systemic therapy.
A 29-year-old male developed acute onset severe shortness of breath and fevers and was found to have a 17 cm anterior mediastinal mass with immature teratoma and possible mixed germ cell tumor on biopsy. He remained hospitalized during ... | CISPLATIN, ETOPOSIDE, IFOSFAMIDE | DrugsGivenReaction | CC BY | 34611488 | 19,980,071 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abortion spontaneous'. | Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient.
Invasive Fungal Sinusitis (IFS) is a potentially life-threatening condition that can progress rapidly to the orbit and the brain, especially if it goes on undetected for a long period. We report a case of a 28-year-old pregn... | VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34611568 | 20,484,811 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient.
Invasive Fungal Sinusitis (IFS) is a potentially life-threatening condition that can progress rapidly to the orbit and the brain, especially if it goes on undetected for a long period. We report a case of a 28-year-old pregn... | VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34611568 | 20,484,811 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nervous system disorder'. | Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient.
Invasive Fungal Sinusitis (IFS) is a potentially life-threatening condition that can progress rapidly to the orbit and the brain, especially if it goes on undetected for a long period. We report a case of a 28-year-old pregn... | VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34611568 | 20,484,811 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Swelling of eyelid'. | Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient.
Invasive Fungal Sinusitis (IFS) is a potentially life-threatening condition that can progress rapidly to the orbit and the brain, especially if it goes on undetected for a long period. We report a case of a 28-year-old pregn... | VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34611568 | 20,484,811 | 2021-12 |
What was the administration route of drug 'VORICONAZOLE'? | Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient.
Invasive Fungal Sinusitis (IFS) is a potentially life-threatening condition that can progress rapidly to the orbit and the brain, especially if it goes on undetected for a long period. We report a case of a 28-year-old pregn... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34611568 | 20,484,811 | 2021-12 |
What was the outcome of reaction 'Abortion spontaneous'? | Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient.
Invasive Fungal Sinusitis (IFS) is a potentially life-threatening condition that can progress rapidly to the orbit and the brain, especially if it goes on undetected for a long period. We report a case of a 28-year-old pregn... | Recovered | ReactionOutcome | CC BY-NC-ND | 34611568 | 20,484,811 | 2021-12 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient.
Invasive Fungal Sinusitis (IFS) is a potentially life-threatening condition that can progress rapidly to the orbit and the brain, especially if it goes on undetected for a long period. We report a case of a 28-year-old pregn... | Recovered | ReactionOutcome | CC BY-NC-ND | 34611568 | 20,484,811 | 2021-12 |
What was the outcome of reaction 'Nervous system disorder'? | Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient.
Invasive Fungal Sinusitis (IFS) is a potentially life-threatening condition that can progress rapidly to the orbit and the brain, especially if it goes on undetected for a long period. We report a case of a 28-year-old pregn... | Recovered | ReactionOutcome | CC BY-NC-ND | 34611568 | 20,484,811 | 2021-12 |
What was the outcome of reaction 'Swelling of eyelid'? | Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient.
Invasive Fungal Sinusitis (IFS) is a potentially life-threatening condition that can progress rapidly to the orbit and the brain, especially if it goes on undetected for a long period. We report a case of a 28-year-old pregn... | Recovered | ReactionOutcome | CC BY-NC-ND | 34611568 | 20,484,811 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalitis toxic'. | Cytarabine-Induced Encephalitis.
Teaching Point: Central nervous system adverse effects of cytarabine treatment include aseptic meningitis, myelopathy, and more rarely, encephalopathy, seizures, and cerebellar dysfunction. This case illustrates a cytarabine-induced encephalitis with predominant cerebellar involvement.
... | CYTARABINE, DAUNORUBICIN | DrugsGivenReaction | CC BY | 34611580 | 19,980,945 | 2021 |
What was the administration route of drug 'DAUNORUBICIN'? | Cytarabine-Induced Encephalitis.
Teaching Point: Central nervous system adverse effects of cytarabine treatment include aseptic meningitis, myelopathy, and more rarely, encephalopathy, seizures, and cerebellar dysfunction. This case illustrates a cytarabine-induced encephalitis with predominant cerebellar involvement.
... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34611580 | 19,980,945 | 2021 |
What was the outcome of reaction 'Encephalitis toxic'? | Cytarabine-Induced Encephalitis.
Teaching Point: Central nervous system adverse effects of cytarabine treatment include aseptic meningitis, myelopathy, and more rarely, encephalopathy, seizures, and cerebellar dysfunction. This case illustrates a cytarabine-induced encephalitis with predominant cerebellar involvement.
... | Recovering | ReactionOutcome | CC BY | 34611580 | 19,980,945 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | PREDNISONE, UPADACITINIB | DrugsGivenReaction | CC BY-NC-ND | 34611997 | 20,983,831 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | ADALIMUMAB, ANAKINRA, AZATHIOPRINE, INFLIXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34611997 | 20,956,058 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | CYCLOPHOSPHAMIDE, IMMUNE GLOBULIN NOS, MYCOPHENOLATE MOFETIL, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34611997 | 20,966,487 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | ADALIMUMAB, ANAKINRA, AZATHIOPRINE, INFLIXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34611997 | 20,956,058 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Steroid dependence'. | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34611997 | 20,983,830 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Symptom recurrence'. | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | AZATHIOPRINE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34611997 | 20,983,836 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | AZATHIOPRINE, METHOTREXATE, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34611997 | 20,983,832 | 2021-10-05 |
What was the administration route of drug 'IMMUNE GLOBULIN NOS'? | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34611997 | 20,966,487 | 2021-10-05 |
What was the dosage of drug 'AZATHIOPRINE'? | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | 2 MILLIGRAM/KILOGRAM, DAILY | DrugDosageText | CC BY-NC-ND | 34611997 | 20,983,836 | 2021-10-05 |
What was the dosage of drug 'IMMUNE GLOBULIN NOS'? | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | 0.4 GRAM, QD, 0.4 G/KG/DAY FOR 5 CONSECUTIVE DAYS EVERY 4 WEEKS | DrugDosageText | CC BY-NC-ND | 34611997 | 20,966,487 | 2021-10-05 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | 2 GRAM, QD, EVERY 4 WEEKS | DrugDosageText | CC BY-NC-ND | 34611997 | 20,966,487 | 2021-10-05 |
What was the dosage of drug 'RITUXIMAB'? | VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis.
OBJECTIVE
We used a clinically oriented phenotype-first approach to identify patients with VEXAS syndrome from a single-center cohort of Italian patients with vasculitis.
METHODS
The clinical records of 147 consecutive male... | 2 GRAM, BIWEEKLY, 2 DOSES OF 1G GIVEN 2 WEEKS APART | DrugDosageText | CC BY-NC-ND | 34611997 | 20,966,487 | 2021-10-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Basedow^s disease'. | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | DARUNAVIR\RITONAVIR, EMTRICITABINE\TENOFOVIR ALAFENAMIDE FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 34612207 | 20,193,635 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood HIV RNA increased'. | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | DARUNAVIR\RITONAVIR, EMTRICITABINE\TENOFOVIR ALAFENAMIDE FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 34612207 | 20,193,635 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | AMPHOTERICIN B, CEFTRIAXONE SODIUM, FLUCONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34612207 | 20,194,845 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | DARUNAVIR\RITONAVIR, EMTRICITABINE\TENOFOVIR ALAFENAMIDE FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 34612207 | 20,193,635 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | AMPHOTERICIN B, CEFTRIAXONE SODIUM, FLUCONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34612207 | 20,194,845 | 2021-10-01 |
What was the administration route of drug 'CEFTRIAXONE SODIUM'? | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34612207 | 20,194,845 | 2021-10-01 |
What was the administration route of drug 'DARUNAVIR\RITONAVIR'? | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34612207 | 20,193,635 | 2021-10-01 |
What was the administration route of drug 'EMTRICITABINE\TENOFOVIR ALAFENAMIDE FUMARATE'? | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34612207 | 20,193,635 | 2021-10-01 |
What was the outcome of reaction 'Basedow^s disease'? | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612207 | 20,193,635 | 2021-10-01 |
What was the outcome of reaction 'Blood HIV RNA increased'? | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612207 | 20,193,635 | 2021-10-01 |
What was the outcome of reaction 'Drug ineffective'? | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612207 | 20,193,635 | 2021-10-01 |
What was the outcome of reaction 'Immune reconstitution inflammatory syndrome'? | Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
Both human immunodeficiency virus (HIV) and antiretroviral therapy (ART) are associated with endocrine dysfunction (1). The term 'immune reconstitution inflammatory syndro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612207 | 20,193,635 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood phosphorus decreased'. | Immobilization-induced hypercalcemia in a patient with renal failure.
Immobilization-induced hypercalcemia is an uncommon cause of elevated calcium which is usually diagnosed following extensive systemic workup and exclusion of more common etiologies. Previously reported cases have largely described this phenomenon in ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34612208 | 19,959,643 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | Immobilization-induced hypercalcemia in a patient with renal failure.
Immobilization-induced hypercalcemia is an uncommon cause of elevated calcium which is usually diagnosed following extensive systemic workup and exclusion of more common etiologies. Previously reported cases have largely described this phenomenon in ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34612208 | 19,959,643 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypocalcaemia'. | Immobilization-induced hypercalcemia in a patient with renal failure.
Immobilization-induced hypercalcemia is an uncommon cause of elevated calcium which is usually diagnosed following extensive systemic workup and exclusion of more common etiologies. Previously reported cases have largely described this phenomenon in ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34612208 | 19,959,643 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Immobilization-induced hypercalcemia in a patient with renal failure.
Immobilization-induced hypercalcemia is an uncommon cause of elevated calcium which is usually diagnosed following extensive systemic workup and exclusion of more common etiologies. Previously reported cases have largely described this phenomenon in ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34612208 | 19,959,643 | 2021-10-01 |
What was the administration route of drug 'DENOSUMAB'? | Immobilization-induced hypercalcemia in a patient with renal failure.
Immobilization-induced hypercalcemia is an uncommon cause of elevated calcium which is usually diagnosed following extensive systemic workup and exclusion of more common etiologies. Previously reported cases have largely described this phenomenon in ... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34612208 | 19,959,643 | 2021-10-01 |
What was the outcome of reaction 'Hypocalcaemia'? | Immobilization-induced hypercalcemia in a patient with renal failure.
Immobilization-induced hypercalcemia is an uncommon cause of elevated calcium which is usually diagnosed following extensive systemic workup and exclusion of more common etiologies. Previously reported cases have largely described this phenomenon in ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34612208 | 19,959,643 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anxiety'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood testosterone increased'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,709,391 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,723,101 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,723,101 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertransaminasaemia'. | Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.
A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed la... | CLENBUTEROL, DROMOSTANOLONE, FLUOXYMESTERONE, LETROZOLE, LEVOTHYROXINE, MESTEROLONE, OXANDROLONE, STANOZOLOL, TRENBOLONE | DrugsGivenReaction | CC BY-NC-ND | 34612209 | 20,723,101 | 2021-10-01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.